Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 38
Filter
Add more filters










Publication year range
1.
Clin Radiol ; 75(3): 209-215, 2020 03.
Article in English | MEDLINE | ID: mdl-31785782

ABSTRACT

AIM: To evaluate the capability of integrated 2-[18F]-fluoro-2-deoxy-d-glucose (FDG)-positron-emission tomography (PET)/magnetic resonance imaging (MRI) to characterise the distinct phenotypes of endometrial cancer. MATERIALS AND METHODS: Thirty-one patients with endometrial cancer (23 with type I, including 17 G1 and six G2 endometrioid adenocarcinomas, and eight with type II, including three G3 endometrioid adenocarcinomas, two carcinosarcomas, and three serous carcinomas) underwent pretreatment FDG-PET/MRI with simultaneous reduced field-of-view diffusion-weighted imaging (DWI). The standardised uptake value (SUV), apparent diffusion coefficient (ADC), and SUV-to-ADC ratio were compared between low-risk (type I and stage I and negative for lymph-vascular space invasion [LVSI]) and high-risk cancers. The diagnostic accuracy for discriminating the cancer phenotypes was evaluated using receiver operating characteristic (ROC) analysis. RESULTS: The SUV was not significantly different between low-risk and high-risk endometrial cancers. High-risk cancers had a significantly lower ADC (756±232×10-6) and a greater SUV-to-ADC ratio (21.7±7.7×109) than low-risk cancers (937±154×10-6, p<0.05 and 13.1±4.1×109, p<0.005, respectively). On comparison of the area under the ROC curves (AUCs), the SUV-to-ADC ratio demonstrated the greatest diagnostic accuracy (ratio 0.83, ADC 0.72, and SUV 0.66). The AUCs for the ratios were significantly higher than those for the SUV values (p<0.05). The optimal SUV-to-ADC cut-off value of 16.9×109 for predicting high-risk cancer revealed a sensitivity of 73%, specificity of 81%, and accuracy of 77%, which was significantly higher than the accuracy for SUV. CONCLUSION: The SUV-to-ADC ratio obtained using integrated FDG-PET/MRI with high-resolution DWI reflects tumour aggressiveness including LVSI, and will be useful for lesion characterisation to decide on an appropriate therapeutic strategy for endometrial cancer.


Subject(s)
Endometrial Neoplasms/diagnostic imaging , Multimodal Imaging , Diffusion Magnetic Resonance Imaging , Female , Fluorodeoxyglucose F18 , Humans , Middle Aged , Neoplasm Grading , Phenotype , Positron-Emission Tomography , Radiopharmaceuticals , Retrospective Studies
2.
Cytopathology ; 29(4): 361-367, 2018 08.
Article in English | MEDLINE | ID: mdl-29768678

ABSTRACT

INTRODUCTION: The aims of the Fukui Cervical Cancer Screening (FCCS) study are to determine the frequency of women with high-risk HPV (hrHPV), whether HPV16 or HPV18 (HPV16/18), in the Japanese cancer screening population for the first time and to identify the best strategy for cervical cancer screening in Japan. METHODS: This study enrolled 7584 women aged ≥25 years who were undergoing routine screening. All women underwent LBC and cobas HPV tests. Women with abnormal cytology, whether hrHPV positive or negative; women with hrHPV positivity with either normal or abnormal cytology; and women randomly selected from women with normal cytology and negative hrHPV negative were referred for colposcopy. RESULTS: The prevalences of hrHPV positivity and HPV16/18 positivity were 6.8% and 1.7%, respectively. The baseline data from the FCCS study showed that the combination of HPV tests and cytology was more sensitive than cytology with respect to the detection of intraepithelial neoplasia grade 2 or worse. However, the specificity (94.1%) of the co-testing strategy that required all women with abnormal cytology or hrHPV positivity to be referred for colposcopy was much lower than that (97.8%) of cytology. The sensitivity and specificity of the co-testing strategy that required only women with abnormal cytology or HPV16/18 positivity to undergo colposcopy were 85.5% and 97.0%, respectively. CONCLUSION: The baseline data from the FCCS study suggest that a cervical cancer screening strategy in which only women with abnormal cytology or HPV16/18 positivity undergo colposcopy offers a more balanced sensitivity and specificity than other strategies.


Subject(s)
Early Detection of Cancer/methods , Human papillomavirus 16/isolation & purification , Human papillomavirus 18/isolation & purification , Mass Screening/methods , Papillomavirus Infections/pathology , Uterine Cervical Neoplasms/pathology , Adult , Aged , Colposcopy , Female , Flow Cytometry , Humans , Japan , Middle Aged , Papillomavirus Infections/virology , Sensitivity and Specificity , Uterine Cervical Neoplasms/virology
3.
Endoscopy ; 45(5): 392-6, 2013.
Article in English | MEDLINE | ID: mdl-23338620

ABSTRACT

A prospective clinical study was conducted to evaluate the safety, feasibility, and efficacy of endoscopic ultrasound (EUS)-guided choledochoduodenostomy (CDS) with direct metallic stent placement using a prototype forward-viewing echoendoscope. The indication for EUS - CDS in this study was lower biliary obstruction only, and not failed endoscopic biliary drainage, because the aim was to evaluate EUS - CDS for first-line biliary drainage therapy. The technical and functional success rates were 94 % (17 /18) and 94 % (16 /17), respectively. Early complications (focal peritonitis) were encountered in two patients (11 %). No patients developed late complications. EUS - CDS with direct metallic stent placement using a forward-viewing echoendoscope was generally feasible and effective for malignant distal biliary tract obstruction. The forward-viewing echoendoscope was useful, especially for deploying the metallic stent.


Subject(s)
Choledochostomy/methods , Cholestasis/surgery , Endosonography , Neoplasms/complications , Ultrasonography, Interventional , Aged , Aged, 80 and over , Choledochostomy/adverse effects , Choledochostomy/instrumentation , Cholestasis/etiology , Drainage , Endosonography/adverse effects , Feasibility Studies , Female , Humans , Male , Middle Aged , Stents , Ultrasonography, Interventional/adverse effects
4.
Gene ; 300(1-2): 79-87, 2002 Oct 30.
Article in English | MEDLINE | ID: mdl-12468089

ABSTRACT

Recent investigations into the translation termination sites of various organisms have revealed that not only stop codons but also sequences around stop codons have an effect on translation termination. To investigate the relationship between these sequence patterns and translation as well as its termination efficiency, we analysed the correlation between strength of consensus and translation efficiency, as predicted according to Codon Adaptation Index (CAI) value. We used RIKEN full-length mouse cDNA sequences and ten other eukaryotic UniGene datasets from NCBI for the analyses. First, we conducted sequence profile analyses following translation termination sites. We found base G and A at position +1 as a strong consensus for mouse cDNA. A similar consensus was found for other mammals, such as Homo sapiens, Rattus norvegicus and Bos taurus. However, some plants had different consensus sequences. We then analysed the correlation between the strength of consensus at each position and the codon biases of whole coding regions, using information content and CAI value. The results showed that in mouse cDNA, CAI value had a positive correlation with information content at positions +1. We also found that, for positions with strong consensus, the strength of the consensus is likely to have a positive correlation with CAI value in some other eukaryotes. Along with these observations, biological insights into the relationship between gene expression level, codon biases and consensus sequence around stop codons will be discussed.


Subject(s)
Eukaryotic Cells/metabolism , Protein Biosynthesis/genetics , Sequence Analysis, DNA/methods , 3' Untranslated Regions/chemistry , 3' Untranslated Regions/genetics , Animals , Base Composition , Humans , Plants/genetics , Rats , Species Specificity
5.
Dev Growth Differ ; 43(6): 633-46, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11737144

ABSTRACT

The present study examines the indispensability of a nucleus or nucleus-deriving factors in the induction of cleavage in Xenopus eggs by testing cleavage in Xenopus eggs fertilized with ultraviolet (UV)-damaged sperm and deprived of the female nucleus. These eggs, which contain only one UV-damaged nucleus with one set of centrioles, undergo unique cleavages. Cleavage takes place in only one of the two blastomeres formed by the immediately preceding cleavage. Histologically, only one nucleus, which does not appear to be organized into typical chromosomes, is found in one of the two blastomeres formed by the immediately preceding cleavage. The typical bipolar spindle and the diastema, or a slit of astral rays, are formed in the blastomere that contains the nucleus. By contrast, only asters lacking the spindle and the diastema are formed in the remaining blastomeres, which do not contain a nucleus. The same results are obtained in eggs that contain two UV-damaged nuclei with one set of centrioles. In these eggs, cleavage appears to occur in one or two blastomeres that contain either or both of the nuclei and one bipolar spindle. In eggs that contain one intact and one UV-damaged nuclei, cleavage takes place quite normally with each blastomere containing one nucleus or one set of chromosomes as well as one bipolar spindle. Thus, there is a very close correlation between the presence of a nucleus and the formation of the mitotic spindle, the diastema and the cleavage furrow in the blastomeres of Xenopus embryos. We conclude that the presence of a nucleus or nucleus-deriving factors is indispensable for the formation of the bipolar spindle, the diastema and the cleavage furrow in the blastomeres of the Xenopus embryos.


Subject(s)
Blastomeres/cytology , Cell Nucleus/ultrastructure , Spindle Apparatus , Animals , Cell Division , Cell Nucleus/radiation effects , Female , Male , Ultraviolet Rays , Xenopus/embryology
6.
Biotechniques ; 31(5): 1042, 1044, 1048-9, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11730011

ABSTRACT

We have developed a method to overcome sequencing problems caused by the presence of homopolymer stretches, such as polyA/T, in cDNA libraries. PolyA tails are shortened by cleaving before cDNA cloning with type IIS restriction enzymes, such as GsuI, placed next to the oligo-dT used to prime the polyA tails of mRNAs. We constructed four rice Cap-Trapper-selected, full-length normalized cDNA libraries, of which the average residual polyA tail was 4 bases or shorter in most of the clones analyzed Because of the removal of homopolymeric stretches, libraries prepared with this method can be used for direct sequencing and transcriptional sequencing without the slippage observed for libraries prepared with currently available methods, thus improving sequencing accuracy, operations, and throughput.


Subject(s)
DNA, Complementary/chemistry , Gene Library , Poly A/chemistry , Sequence Analysis, DNA/methods , Animals , Mice , Mice, Inbred C57BL , Transfection
7.
Mamm Genome ; 12(9): 673-7, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11641714

ABSTRACT

Although the sequencing of the human genome is complete, identification of encoded genes and determination of their structures remain a major challenge. In this report, we introduce a method that effectively uses full-length mouse cDNAs to complement efforts in carrying out these difficult tasks. A total of 61,227 RIKEN mouse cDNAs (21,076 full-length and 40,151 EST sequences containing certain redundancies) were aligned with the draft human sequences. We found 35,141 non-redundant genomic regions that showed a significant alignment with the mouse cDNAs. We analyzed the structures and compositional properties of the regions detected by the full-length cDNAs, including cross-species comparisons, and noted a systematic bias of GENSCAN against exons of small size and/or low GC-content. Of the cDNAs locating the 35,141 genomic regions, 3,217 did not match any sequences of the known human genes or ESTs. Among those 3,217 cDNAs, 1,141 did not show any significant similarity to any protein sequence in the GenBank non-redundant protein database and thus are candidates for novel genes.


Subject(s)
Computational Biology/methods , DNA, Complementary/genetics , Algorithms , Animals , Databases, Factual , Exons , Genome, Human , Humans , Introns , Mice , Molecular Sequence Data , Sequence Analysis, DNA/methods , Sequence Homology, Nucleic Acid
8.
Gene ; 276(1-2): 101-5, 2001 Oct 03.
Article in English | MEDLINE | ID: mdl-11591476

ABSTRACT

The codon adaptation index (CAI) values of all protein-coding sequences of the full-length cDNA libraries of Mus musculus were computed based on the RIKEN mouse full-length cDNA library. We have also computed the extent of consensus in flanking sequences of the initiator ATG codon based on the 'relative entropy' values of respective nucleotide positions (from -20 to +12 bp relative to the initiator ATG codon) for each group of genes classified by CAI values. With regard to the two nucleotides positions (-3 and +4) known to be highly conserved in Kozak's consensus sequence, a clear correlation between CAI values and relative entropy values was observed at position -3 but this was not significant at position +4, although a significant correlation was found at position -1 of the consensus sequence. Further, although no correlation was observed at any additional positions, relative entropy values were very high at positions -4, -6, and -8 in genes with high CAI values. These findings suggest that the extent of conservation in the flanking sequence of the initiator ATG codon including Kozak's consensus sequence was an important factor in modulation of the translation efficiency as well as synonymous codon usage bias particularly in highly expressed genes.


Subject(s)
5' Untranslated Regions/genetics , Codon/genetics , DNA, Complementary/genetics , Animals , Base Composition , Conserved Sequence , DNA-Directed RNA Polymerases/genetics , Genes/genetics , Heat-Shock Proteins/genetics , Mice , Peptide Elongation Factors/genetics , Ribosomal Proteins/genetics
9.
Int J Hematol ; 73(4): 526-31, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11503969

ABSTRACT

We report here a lupus anticoagulant (LA)-like activity observed in a 45-year-old man with Bence-Jones protein (BJP) lambda-type multiple myeloma. This patient showed no clinical symptoms of thrombosis or bleeding diathesis. Laboratory examination on admission showed mild anemia, prolongation of activated partial thromboplastin time (APTT) (APTT, 56.2 seconds; control, 29.1 seconds), normal prothrombin time, normal thrombin time, and massive proteinuria (2.3 g/d). The mix test with normal plasma showed the presence of circulating anticoagulant. Based on the assumption that the lambda-type BJP may have been responsible for the prolongation of APTT, we purified the BJP from the patient's urine using column works. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotting showed that the purified protein was a 48-kd homodimer of immunoglobulin lambda-chains. Addition of the purified dimeric lambda-type BJP to the normal plasma prolonged both APTT and dilute Russell's viper venom time (DRVVT) in a dose-dependent manner, and the negatively charged phospholipid-dependent prothrombinase activity was significantly inhibited in the presence of this protein. Furthermore, both the prolongation of DRVVT and the inhibition of the prothrombinase activity were almost completely abrogated under the condition of high ionic strength. These findings collectively suggest that the dimeric lambda-type BJP showed LA-like activity via the mechanism of ionic charge.


Subject(s)
Bence Jones Protein/pharmacology , Lupus Coagulation Inhibitor , Multiple Myeloma/blood , Bence Jones Protein/isolation & purification , Bence Jones Protein/urine , Blood Coagulation/drug effects , Dimerization , Humans , Immunoglobulin lambda-Chains/isolation & purification , Immunoglobulin lambda-Chains/pharmacology , Immunoglobulin lambda-Chains/urine , Male , Middle Aged , Partial Thromboplastin Time
10.
Dev Growth Differ ; 43(4): 401-13, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11473547

ABSTRACT

This paper describes success in delaying the onset of gastrulation in Xenopus laevis embryos without damage to their subsequent development by temporarily arresting cleavage with urethane. Exposure of X. laevis embryos to 150 mM urethane before gastrulation resulted in cleavage arrest and its removal led to cleavage resumption. During cleavage arrest, cyclic activities including nuclear replication and the M-phase-promoting factor cycle continued, although their duration was lengthened to nearly 1.8-fold that of the controls. Because of a 30-min time lag from removal of urethane to resumption of cleavage, as well as the retardation of cyclic activities during cleavage arrest, the development of embryos after a 60-min exposure to urethane lagged two cell cycles behind that of control embryos. Here, the two cell cycle delay is equivalent to 50 min at 22-23 degrees C. The start of gastrulation in exposed embryos was accordingly delayed about 50 min, although the delay in mid-blastula transition was as little as 20-25 min. Consistent results were obtained in embryos exposed to urethane for 90 or 120 min and those exposed to procaine or NH4Cl for 60 min. Although these results imply that delay in the start of gastrulation in exposed embryos is ascribed simply to delay in their development raised by cleavage arrest, at the same time they suggest that the onset of gastrulation is timed by systems sensitive to urethane, procaine and NH4Cl in X. laevis embryos.


Subject(s)
Cell Cycle/drug effects , Gastrula/physiology , Urethane/pharmacology , Ammonium Chloride/pharmacology , Animals , Cell Cycle/physiology , Cell Nucleus/metabolism , Cleavage Stage, Ovum/physiology , Female , Fluorescent Dyes/metabolism , Gastrula/drug effects , Indoles/metabolism , Microscopy, Fluorescence , Procaine/pharmacology , Time Factors , Xenopus laevis
11.
Exp Hematol ; 29(5): 616-22, 2001 May.
Article in English | MEDLINE | ID: mdl-11376875

ABSTRACT

OBJECTIVE: Human blood platelets are easily available physiologic target cells for thrombopoietin (TPO). TPO up-regulates platelet aggregation and alpha-granule secretion induced by various agonists. We investigated the role of phosphatidylinositol 3-kinase (PI3K) and its association with Gab1 in TPO-mediated up-regulation of platelet function. MATERIALS AND METHODS: PI3K inhibitors (wortmannin and LY294002) and a MAP/ERK-kinase (MEK) inhibitor (PD98059) were used to investigate the role of these kinases in TPO-mediated up-regulation of platelet function. To elucidate the molecules associated with PI3K, we performed immunoprecipitation and pull-down experiments followed by immunoblotting. In vitro kinase assay also was performed to detect extracellular signal-regulated kinase (ERK) kinase activity. RESULTS: TPO up-regulated platelet alpha-granule secretion and aggregation induced by thrombin, which was dose-dependently inhibited by preincubation with wortmannin or LY294002. Immunoprecipitation and pull-down experiments revealed that regulatory subunit of PI3K, p85, was rapidly associated with tyrosine-phosphorylated Gab1 via its n- and c-terminal SH2 domains. Pretreatment of platelets with TPO dramatically augmented the thrombin-induced ERK activation, which was almost completely inhibited by LY294002. Furthermore, a MEK inhibitor, PD98059, not completely but significantly inhibited TPO-mediated up-regulation of thrombin-induced alpha-granule secretion. CONCLUSION: TPO induces the association of tyrosine-phosphorylated Gab1 with p85-PI3K. In downstream signaling, ERK is PI3K-dependently activated, which plays a critical role for TPO-mediated up-regulation of platelet function.


Subject(s)
MAP Kinase Kinase Kinase 1 , MAP Kinase Signaling System/drug effects , Phosphatidylinositol 3-Kinases/physiology , Phosphoproteins/physiology , Platelet Aggregation/drug effects , Thrombopoietin/pharmacology , Adaptor Proteins, Signal Transducing , Androstadienes/pharmacology , Blood Platelets/metabolism , Chromones/pharmacology , Cytoplasmic Granules/metabolism , Enzyme Inhibitors/pharmacology , Flavonoids/pharmacology , Humans , Mitogen-Activated Protein Kinase 1/antagonists & inhibitors , Mitogen-Activated Protein Kinase 3 , Mitogen-Activated Protein Kinases/antagonists & inhibitors , Morpholines/pharmacology , Protein Serine-Threonine Kinases/antagonists & inhibitors , Thrombin/pharmacology , Wortmannin
12.
Nature ; 409(6821): 685-90, 2001 Feb 08.
Article in English | MEDLINE | ID: mdl-11217851

ABSTRACT

The RIKEN Mouse Gene Encyclopaedia Project, a systematic approach to determining the full coding potential of the mouse genome, involves collection and sequencing of full-length complementary DNAs and physical mapping of the corresponding genes to the mouse genome. We organized an international functional annotation meeting (FANTOM) to annotate the first 21,076 cDNAs to be analysed in this project. Here we describe the first RIKEN clone collection, which is one of the largest described for any organism. Analysis of these cDNAs extends known gene families and identifies new ones.


Subject(s)
Computational Biology , DNA, Complementary , Mice/genetics , Animals , Chromosome Mapping , Enzymes/genetics , Gene Library , Genome , Humans , Mice, Inbred C57BL , Protein Biosynthesis , Protein Structure, Tertiary , RNA, Messenger , Sequence Analysis, DNA
13.
Dev Growth Differ ; 42(6): 581-91, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11142680

ABSTRACT

The present study examines putative blastopore determinants in uncleaved Xenopus eggs. Deletion of marginal and lower portions of Xenopus eggs when between 30 and 50% of the first cell cycle has been completed (0.3-0.5 normalized time (NT)) results in the complete absence of the blastopore, while deletion of the vegetal hemisphere during the same period leads to the formation of a smaller blastopore. Extrusion of only yolk and deep cytoplasm of the vegetal hemisphere during 0.3-0.5 NT does not affect the formation or size of the blastopore. Consistently, transplantation of cortical and subcortical cytoplasm from marginal, but not other, sites of eggs at 0.3-0.5 NT to an animal blastomere from 16-cell stage embryos induces an ectopic blastopore and bottle cell-like cells. This does not occur in the same transplantation from eggs at 0.2 NT. These results suggest that the blastopore determinants become localized to the marginal cortical and/or subcortical cytoplasm during 0.2-0.3 NT. Other results suggest the involvement of a hexyleneglycol-sensitive system in the process of localization of the blastopore determinants to the marginal region during 0.2-0.3 NT. The properties and behavior of the putative blastopore determinants are discussed in relation to those of VegT, which previously has been shown to induce ectopic blastopores.


Subject(s)
Embryo, Nonmammalian/cytology , Ovum/cytology , Animals , Embryology , Female , Xenopus laevis
14.
Int J Hematol ; 72(4): 477-83, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11197216

ABSTRACT

We analyzed the clinicopathological features of 5 Japanese patients with CD56+ primary cutaneous lymphomas (3 men and 2 women aged 25 to 73 years). Except for 1 patient in whom bone marrow involvement was simultaneously observed, all patients presented with cutaneous lesions. Based on their Epstein-Barr virus (EBV) status, we categorized these patients into 2 groups, namely EBV-encoded small RNA-1 (EBER-1) (3 patients) and EBER-1- (2 patients). Generalized lymphadenopathy and bone marrow involvement were observed only in EBER-1 patients. Morphologically, angiocentric proliferation was more prominent in EBER-1+ patients and was accompanied by panniculitis-like changes. The lymphomas in EBER-1- patients featured monomorphic proliferation of lymphoblastic cells with no cytoplasmic granules. Phenotypically, CD3-, cytoplasmic CD3 epsilon+, and CD56+ were common findings in both types. The EBER-1- type showed an additional distinguishing feature, CD7+, CD4+, CD8-, HLA-DR+, and terminal deoxynucleotidyl transferase-positive (TdT+) phenotype. The lymphoma was primarily resistant in the EBER-1+ type, and the patients died within 6 months of admission. In contrast, the lymphoma in the EBER-1- patients was originally chemosensitive. Collectively, we consider there to be at least 2 types of CD56+ primary cutaneous lymphomas, corresponding to nasal-type natural killer (NK)/T-cell lymphomas (EBER-1+) and blastic NK-cell lymphomas (EBER-1-).


Subject(s)
CD56 Antigen , Lymphoma/pathology , Lymphoma/virology , Skin Neoplasms/virology , Adult , Aged , Bone Marrow Neoplasms/etiology , Bone Marrow Neoplasms/pathology , Female , Humans , Japan , Killer Cells, Natural/pathology , Lymphoma/classification , Male , Middle Aged , Nose Neoplasms/etiology , Nose Neoplasms/pathology , Nose Neoplasms/virology , RNA, Viral/blood , Skin Neoplasms/immunology , Skin Neoplasms/pathology , T-Lymphocytes/pathology
15.
Cancer Genet Cytogenet ; 115(1): 62-4, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10565302

ABSTRACT

A rare association of der(1;7)(q10;p10) with de novo acute erythroblastic leukemia (AML-M6) in a 63-year-old male is reported. While this unbalanced 1;7 translocation, der(1;7), has been reported often in therapy-related myelodysplastic syndrome (t-MDS) or therapy-related acute myeloid leukemia (t-AML), its associations with de novo AML-FAB-M6 have rarely been reported. Although der(1;7) has been reported as a cytogenetic factor for poor prognosis in t-MDS/AML, our patient showed a good response to chemotherapy and obtained complete remission, although longer observation is required to evaluate the prognosis.


Subject(s)
Chromosomes, Human, Pair 1 , Chromosomes, Human, Pair 7 , Leukemia, Erythroblastic, Acute/genetics , Translocation, Genetic , Aged , Bone Marrow Cells/pathology , Humans , Karyotyping , Leukemia, Erythroblastic, Acute/pathology , Lymphocyte Subsets , Male
16.
Cancer Genet Cytogenet ; 109(1): 72-5, 1999 Feb.
Article in English | MEDLINE | ID: mdl-9973964

ABSTRACT

The t(8;21)(q22;q22) is the second-most frequently observed nonrandom karyotypic abnormality associated with acute myelogenous leukemia (AML), especially in FAB M2. Trisomy 4 is also a specific chromosomal abnormality for AML FAB M2 or M4. We experienced a 37-year-old woman with a morphologically AML FAB M2 carrying a rare complex translocation (6;21;8)(p21;q22;q22) resulting in AML1 gene rearrangement. A subclone with an additional chromosomal abnormality, trisomy 4, was also revealed. Similarly to the typical t(8;21), a conventional chemotherapy successfully induced into complete remission associated with a recovery of normal karyotype, 46,XX, although AML1/MTG8 (ETO) chimera mRNA was detected by reverse transcriptase polymerase chain reaction.


Subject(s)
Chromosomes, Human, Pair 21 , Chromosomes, Human, Pair 4 , Chromosomes, Human, Pair 6 , Chromosomes, Human, Pair 8 , Leukemia, Myeloid, Acute/genetics , Translocation, Genetic , Trisomy , Adult , Chromosome Banding , Chromosome Mapping , Core Binding Factor Alpha 2 Subunit , DNA-Binding Proteins/genetics , Female , Genetic Variation , Humans , Karyotyping , Leukemia, Myeloid, Acute/pathology , Proto-Oncogene Proteins/genetics , RNA, Messenger/genetics , RUNX1 Translocation Partner 1 Protein , Recombinant Fusion Proteins/biosynthesis , Reverse Transcriptase Polymerase Chain Reaction , Transcription Factors/genetics
17.
Acta Neuropathol ; 96(4): 347-50, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9796998

ABSTRACT

Membrane-type 3 matrix metalloproteinase (MT3-MMP) is a novel MT-MMP which has a transmembrane domain at the C terminus, and mediates activation of pro-gelatinase A, just as does MT1-MMP. Previously, we reported that MT1-MMP was expressed on microglial cells only in the white matter [Yamada T, Yoshiyama Y, Sato H, Seiki M, Shinagawa A, Takahashi M (1995) Acta Neuropathol 90:421-424]. In the present study of both non-neurological and Alzheimer brain tissues, we examined the localization of MT3-MMP by immunohistochemistry. Anti-MT3-MMP antibodies gave positive staining of microglial cells in all brain tissues. Positively stained microglia were found not only in the white matter but also in the gray matter. Reverse transcriptase-polymerase chain reaction for MT3-MMP mRNA showed the same amount of expression in gray and white matters, while that for gelatinase A and MT1-MMP mRNA expressed much higher in the white matter than in the gray matter. These results suggest that MT3-MMP may play a role on microglial cells, although its role may be different from MT1-MMP in the brain.


Subject(s)
Brain/enzymology , Matrix Metalloproteinase 3/metabolism , Aged , Aged, 80 and over , Alzheimer Disease/enzymology , Blotting, Western , Female , Humans , Immunohistochemistry , Male , Matrix Metalloproteinase 3/genetics , Middle Aged , RNA, Messenger/metabolism , Reference Values , Reverse Transcriptase Polymerase Chain Reaction
18.
J Obstet Gynaecol Res ; 24(2): 161-6, 1998 Apr.
Article in English | MEDLINE | ID: mdl-9631607

ABSTRACT

A well-differentiated endometrioid adenocarcinoma coexistent with benign and borderline-malignant endometrioid adenofibroma was found in the ovary of a 64-year-old woman. She had vaginal bleeding caused by simple hyperplasia of the endometrium due to high levels of sex steroid hormones. A FIGO stage Ia solid ovarian tumor was identified. It was composed of irregularly shaped endometriotic glands with benign and borderline malignant cytologic features embedded in abundant fibromatous stroma. Well-differentiated malignant epithelium was adjacent to these areas, but fibromatous stroma was not predominant. She was treated by surgery and three cycles of chemotherapy. This paper describes this unusual tumor and reviews the literature.


Subject(s)
Adenofibroma/pathology , Carcinoma, Endometrioid/pathology , Neoplasms, Multiple Primary/pathology , Ovarian Neoplasms/pathology , Adenofibroma/drug therapy , Adenofibroma/surgery , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Carcinoma, Endometrioid/drug therapy , Carcinoma, Endometrioid/surgery , Chemotherapy, Adjuvant , Cisplatin/administration & dosage , Cyclophosphamide/administration & dosage , Female , Humans , Middle Aged , Necrosis , Neoplasms, Multiple Primary/drug therapy , Neoplasms, Multiple Primary/surgery , Ovarian Neoplasms/drug therapy , Ovarian Neoplasms/surgery , Remission Induction
19.
Biol Pharm Bull ; 20(8): 843-9, 1997 Aug.
Article in English | MEDLINE | ID: mdl-9300128

ABSTRACT

Tumor metastasis into distinct organs and tissues, of which many patients with malignancies die, is regulated in multiple steps. Using a murine metastasis model, in which highly metastatic B16-BL6 melanoma cells were inoculated i.v. into syngeneic C57BL/6 mice, the administration of a recombinant human tissue inhibitor of metalloproteinases-2 (r-hTIMP-2) once a day on days -1 to 3 after the implantation significantly inhibited the formation of metastatic foci in the lungs. The antimetastatic effect of r-hTIMP-2 was detected irrespective of administration route [i.v., i.p., s.c., and i.m. routes] and in a dose-dependent manner. The i.m.-injection of r-hTIMP-2 during the early phase after tumor inoculation is suggested to be essential for antimetastasis. In another model using spontaneously metastasing B16-BL6 cells, multiple i.m.-injections of r-hTIMP-2 also resulted in a reduced but not statistically significant number of pulmonary metastases. In addition to these antimetastatic effects, a slight inhibitory effect on tumor cell growth was observed in vitro and in vivo. In conclusion, the antimetastasis by r-hTIMP-2 may be due to inhibition of the degradation of the extracellular matrix by matrix metalloproteinases (MMPs) and, in part, to the suppression of the tumor cell growth.


Subject(s)
Antineoplastic Agents/pharmacology , Enzyme Inhibitors/pharmacology , Melanoma, Experimental/drug therapy , Metalloendopeptidases/antagonists & inhibitors , Neoplasm Metastasis/prevention & control , Protease Inhibitors/pharmacology , Animals , Antineoplastic Agents/pharmacokinetics , Cell Movement/drug effects , Enzyme Inhibitors/pharmacokinetics , Gelatin/chemistry , Humans , Infusions, Parenteral , Mice , Protease Inhibitors/chemistry , Protease Inhibitors/pharmacokinetics , Tumor Cells, Cultured
20.
Rinsho Ketsueki ; 38(1): 64-71, 1997 Jan.
Article in Japanese | MEDLINE | ID: mdl-9028164

ABSTRACT

We reported a rare case of pancytopenia caused by allopurinol. A 61-year-old man was first admitted in May 1993, because of thrombocytosis. He had suffered from chronic glomerulonephritis. He was administered allopurinol for hyperuricemia from March 1993. On first admission the laboratory findings revealed leukocytosis (10,100/microliter) and thrombocytosis (971 x 10(3)/microliter) in the peripheral blood. Myelofibrosis was strongly suspected due to increased number of MgK and reticular fiber in the bone marrow. Two months later, he readmitted due to pancytopenia (WBC 1,300/microliter, Hb 6.2g/dl, Plt 10 x 10(3)/microliter). His bone marrow showed markedly hypocellular. Because we suspected that pancytopenia was induced by allopurinol, we discontinued allopurinol and administered oxymetholone, G-CSF, and EPO, WBC, RBC, and platelet count had been recovered about one and half months later. In vitro co-culture indicated that CFU-G, E, and Meg in the bone marrow cells after recovery from pancytopenia were markedly suppressed in the presence of patient's serum and oxipurinol. Pancytopenia due to allopurinol was reported to be rare, and some authors showed that it will sometimes be fatal. Because pancytopenia of this case had been recovered in a relatively short time with cytokine therapy, it was thought to be effective for pancytopenia due to drug like this case.


Subject(s)
Allopurinol/adverse effects , Antimetabolites/adverse effects , Myeloproliferative Disorders/drug therapy , Pancytopenia/chemically induced , Drug Therapy, Combination , Erythropoietin/administration & dosage , Granulocyte Colony-Stimulating Factor/administration & dosage , Humans , Male , Middle Aged , Oxymetholone/administration & dosage , Pancytopenia/therapy , Recombinant Proteins/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...